Cyclo Therapeutics (CYTH) Financials

$0.72

$0.00 (0.00%)

As on 27-Mar-2025 09:30EDT

Market cap

$24 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

59.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	1.08	1.08	1.38	1.59	0.90	1.01
Cost of Revenue	0.10	3.49	0.14	0.16	0.07	0.08
Gross Profit	0.98	-2.41	1.24	1.43	0.84	0.93
Operating Expenses	21.04	17.64	16.85	15.70	9.80	8.32
Operating Profit (EBIT)	-20.05	-20.05	-15.61	-14.27	-8.96	-7.39
Other Income	--	--	--	--	--	--
Profit before Tax	-20.06	-20.06	-15.45	-14.29	-8.94	-7.53
Provision for Tax	--	0.00	-0.17	0.02	-0.02	0.14
Profit after Tax (Net Income)	-20.06	-20.06	-15.28	-14.31	-8.92	-7.67
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-15.45	-14.29	-8.94	-7.53

Liabilities ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	4.76	4.76	0.73	15.67	10.45	0.94
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.02	0.02	3.48	0.02	0.06	0.04
Current Liabilities	8.47	8.47	3.48	3.83	3.67	3.14
Total Liabilities	13.25	13.25	4.22	19.52	14.19	4.11

Assets ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.93	0.93	0.06	0.08	0.14	0.16
Current Assets	12.32	12.32	4.16	19.44	14.05	3.96
Total Assets	13.25	13.25	4.22	19.52	14.19	4.11
Total Debt*	1.03	1.03	--	0.17	0.19	0.05
Net Current Assets	--	3.85	0.68	15.61	10.38	0.82

Cashflow ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	-16.19	-16.19	-15.11	-15.01	-8.54	-6.59
Cash Flow from Investing Activities	--	--	0.04	0.01	-0.01	0.04
Cash from Financing Activities	23.89	23.89	0.01	18.76	18.62	7.12
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-0.70	-0.81	-1.81	-2.22	-1.67	-6.34
Cash EPS ($)	-0.70	-0.81	-1.80	-2.22	-1.67	-6.33
Adjusted Book Value ($)	0.17	0.19	0.09	2.43	1.96	0.77
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.56	-0.65	-1.79	-2.33	-1.60	-5.44
Free Cash Flow per Share ($)	-0.56	-0.65	-1.79	-2.33	-1.61	-5.44

Profitability Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	-346.41	-614.81	-184.35	-108.01	-153.38	-774.78
ROE (%)	-421.64	-730.48	-186.27	-109.52	-156.70	-795.88
ROA (%)	-151.40	-229.72	-128.75	-84.88	-97.51	-218.30
EBIT Margin (%)	-1,862.69	-1,862.69	-1,135.51	-900.94	-991.99	-733.80
Net Margin (%)	-1,863.36	-1,863.36	-1,110.65	-902.10	-987.75	-761.94
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	-0.22	-0.13	0.76	-0.10	0.00
EBIT Growth (%)	--	-28.35	-9.35	-59.42	-21.25	-73.70
Net Profit Growth (%)	--	-31.27	-6.81	-60.32	-16.27	-80.36
EPS Growth (%)	0.13	0.55	0.19	-0.33	0.74	-0.30
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	-0.85	-1.97	-0.79	-1.68	-2.60	-0.05
Price / Book Value	3.56	8.31	16.36	1.53	2.22	0.44
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.44	-1.56	-0.67	-0.53	-1.18	0.31
Close Price ($)	0.59	1.59	1.42	3.73	4.35	34.00
High Price ($)	2.12	2.57	5.12	17.75	34.99	84.00
Low Price ($)	0.55	0.67	0.91	3.43	3.40	15.50
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	0.22	0.22	--	0.01	0.02	0.06
Short term debt to equity ratio	0.21	0.42	--	0.01	0.01	0.04
Current Ratio	1.45	1.45	1.19	5.07	3.83	1.26
Quick Ratio	1.42	1.42	1.12	5.01	3.76	1.18
Interest Coverage	--	--	-103.83	-771.33	--	--

Operating Efficiency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	11.37	11.37	4.00	34.00	12.37	18.12
Asset Turnover	0.08	0.12	0.12	0.09	0.10	0.29
Receivable days	41.53	30.09	78.86	74.96	59.49	54.39
Inventory Days	943.57	26.65	633.50	544.49	1,321.70	1,594.58
Payable days	18,016.29	371.39	7,771.28	8,446.78	18,333.95	12,216.61
Cash Conversion Cycle	-17,031.19	-314.65	-7,058.91	-7,827.33	-16,952.75	-10,567.64